3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid

Basic Information

View in Editor

CAS Number

1260-17-9

Molecular Formula

C22H20O13

Molecular Weight

492.39 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

Boiling Point

907.6°C at 760 mmHg

Flash Point

316.1ºC

Solubility

Insuluble (3.5E-3 g/L) (25 ºC),

Refractive Index

1.6000 (estimate)

Specific Rotation

15654 +51.6° (water)

SMILES

View in Editor

CC1=C(C(O)=O)C(O)=CC2=C1C(=O)C1=C(O)C([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=C(O)C(O)=C1C2=O

InChI

InChI=1S/C22H20O13/c1-4-8-5(2-6(24)9(4)22(33)34)13(25)10-11(15(8)27)16(28)12(18(30)17(10)29)21-20(32)19(31)14(26)7(3-23)35-21/h2,7,14,19-21,23-24,26,28-32H,3H2,1H3,(H,33,34)/t7-,14-,19+,20-,21+/m1/s1

InChIKey

DGQLVPJVXFOQEV-JNVSTXMASA-N

LogP

-1.1940800000000005

Topological Polar Surface Area

242.50999999999996 Å²

Hydrogen Bond Donor/Acceptor

9 / 13

Complexity

864

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

Carminic acid
Cochineal Carmine Powder
Carminic Acid (Natural dye)
CARMINE
CARMINIC ACID(RG)
22948<BR> CARMINIC ACID
2-ANTHRACENECARBOXYLICACID, 7-B-D-GLUCOPYRANOSYL-9,10-DIHYDRO-3,5,6,8-TETRAHYDROXY-1-METHYL-9,10-DIOXO-
7-beta-D-Glucopyranosyl-9,10-Dihydro-3,5,6,8-Tetrahydroxy-1-Methyl-9,10-Dioxo-2-Anthracenecarboxylicacid
Aloesaponarin II
Carmin <Carminsaeure>
CARMINE PICRO
Carminic
CARMINIC ACID (C.I. 75470) DC
Carminic acid (E120)
E120
Karminsure
natural red 4
C.I. 75470
C.I. Natural Red 4
Carmine 5297
Cochineal Red PWD
E 120 (dye)
NSC 326224
Natural Red 2180
San Red 1
San-Ei Gen San Red 1
Sun Red 1
Sun Red No. 1
7-beta-D-Glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid
E 120

MDL Number

MFCD00167028

Customs Code

32129000

FAQ

What regulatory guidelines apply to 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS: 1260-17-9)?

3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS 1260-17-9) falls under the scope of various regulatory guidelines such as REACH for registration, evaluation, authorization, and restriction of chemicals in the European Union, GHS for classification and labeling, and FDA/EPA requirements for use in pharmaceuticals and environmental monitoring. Compliance with these regulations is essential to ensure safety and legal adherence.

Are there alternatives to 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS: 1260-17-9) in synthesis?

There are several alternatives to 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS 1260-17-9) in synthesis, including derivatives with similar functional groups such as 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxoanthracene-2-carboxylic acid. Common alternative reagents include hydroxylated derivatives, isomers, and analogs which can offer similar or improved properties in different applications.

What is the market or research trend for 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS: 1260-17-9)?

The market for 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS 1260-17-9) is driven by its applications in pharmaceuticals, cosmetics, and environmental remediation. Recent research trends focus on its use in drug development, as a potential antioxidant, and in the synthesis of novel materials. The trend suggests increasing demand and innovation in its use across various industries.

How should waste containing 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS: 1260-17-9) be handled?

Waste containing 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid (CAS 1260-17-9) should be handled according to hazardous waste regulations. Collection of waste should be done in appropriate containers, and incineration or professional waste disposal services are recommended to ensure compliance with environmental protection standards. Special precautions should be taken to prevent environmental contamination and to ensure the safety of waste handlers during disposal processes.